KORA SAÚDE PARTICIPAÇÕES S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.87 BRL | +16.00% |
|
+35.94% | -33.08% |
| Feb. 28 | Transcript : Kora Saúde Participações S.A., Q4 2023 Earnings Call, Feb 28, 2024 | |
| Feb. 27 | Kora Saúde Participações S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2024 * | 2.42B 470M | Sales 2025 * | 2.53B 491M | Capitalization | 661M 128M |
|---|---|---|---|---|---|
| Net income 2024 * | -51M -9.9M | Net income 2025 * | 23M 4.47M | EV / Sales 2024 * | 1.24 x |
| Net Debt 2024 * | 2.34B 454M | Net Debt 2025 * | 2.16B 420M | EV / Sales 2025 * | 1.12 x |
| P/E ratio 2024 * |
-14.6
x | P/E ratio 2025 * |
15
x | Employees | - |
| Yield 2024 * |
1.16% | Yield 2025 * |
1.16% | Free-Float | 81.25% |
More Fundamentals
* Assessed data
More news
Latest transcript on Kora Saúde Participações S.A.
| 1 day | +13.33% | ||
| 1 week | +32.81% | ||
| Current month | +3.66% | ||
| 3 months | -15.00% | ||
| 6 months | +6.25% | ||
| Current year | -34.62% |
1 week
0.65
0.90
1 month
0.630.90
Current year
0.631.30
1 year
0.631.68
3 years
0.639.46
5 years
0.639.46
10 years
0.639.46
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | 59 | 10-11-30 | |
Elias Leal Lima
DFI | Director of Finance/CFO | 33 | 17-12-31 |
| Chief Tech/Sci/R&D Officer | - | 22-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | 59 | 10-11-30 | |
Eduardo da Veiga
BRD | Director/Board Member | 38 | - |
| Founder | 52 | 10-11-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 0.87 | +16.00% | 1 455 700 |
| 24-04-23 | 0.86 | +14.67% | 2,087,700 |
| 24-04-22 | 0.75 | -1.32% | 957,300 |
| 24-04-19 | 0.76 | +8.57% | 678,000 |
| 24-04-18 | 0.7 | +9.37% | 1,936,200 |
Delayed Quote Sao Paulo, April 24, 2024 at 09:35 am EDT
More quotes
Kora Saude Participacoes SA is a Brazil-based hospital network. With a presence in the management of hospital beds in five states (Espirito Santo, Mato Grosso, Tocantins, Goiania and Ceara) and in the satellite cities of the Federal District, the Company also operates a park offering diagnostic and therapeutic support services, including oncology, clinical, radiology, hemodynamics and others. The Company has hospital expansion (brownfields) and hospital construction (greenfields) projects. The vast majority of professionals who provide services in the Company's hospitals are independent.
Calendar
2024-04-29
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
0.86
BRL
Average target price
1.55
BRL
Spread / Average Target
+80.23%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -34.62% | 128M | |
| -23.64% | 15.55B | |
| +0.90% | 12.05B | |
| +3.48% | 11.5B | |
| +10.15% | 10.69B | |
| +23.43% | 8.26B | |
| -0.40% | 7.79B | |
| +22.54% | 7.31B | |
| +5.61% | 6.75B | |
| +45.79% | 4.51B |
- Stock Market
- Equities
- KRSA3 Stock
